Showing results (661-670 of 668) with videos related to

Sort By:
Pageof 67
You have reached the last page of results.This site can display upto 668 results.
Experimental Neurobiology|March 21, 2015
COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK PathwayHyo Eun Moon, Kyunghee Byun, Hyung Woo Park, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2014
A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancerHyun Chang, Sung Kwan Shin, Byoung Chul Cho, et al.
Korean Circulation Journal|March 3, 2021
Sodium/glucose Co-Transporter 2 Inhibitor, Empagliflozin, Alleviated Transient Expression of SGLT2 after Myocardial InfarctionSoo Yong Lee, Tae Wook Lee, Gyu Tae Park, et al.
Cell Stem Cell|December 12, 2023
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's diseaseSanghyun Park, Chan Wook Park, Jang Hyeon Eom, et al.
Biomaterials|December 23, 2019
NFATc1+CD31+CD45- circulating multipotent stem cells derived from human endocardium and their therapeutic potentialHan-Mo Yang, Ju-Young Kim, Hyun-Jai Cho, et al.
Oncotarget|December 25, 2014
Fibroblast growth factor receptor 1 gene amplification is associated with poor survival in patients with resected esophageal squamous cell carcinomaHyo Song Kim, Seung Eun Lee, Yoon Sung Bae, et al.
Cell|October 14, 2025
Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's diseaseJin Woo Chang, Han Kyu Na, Kyung Won Chang, et al.
Oncotarget|October 14, 2015
Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinomaHyo Song Kim, Sung-Moo Kim, Hyunki Kim, et al.
Pageof 67